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ABSTRACT
Late stage Parkinson`s disease (PD) is characterized by significant worsening of symptoms, motor fluctua-
tions and decrease of effectiveness of drug therapy. Decimeter wave therapy (DWT) is one option to enlarge
treatment strategy in late PD. We studied the effect of DWT in 12 patients (7 males), aged 65,83± 4,02 years,
with 6,42± 1,51 years disease duration. Seven were at Hoehn- Yahr stage III and remaining 5 at stage IV.
Mean UPDRS total score sum was 39,25± 1,91, and mean UPDRS part III sum was 24,67± 2,1. DMW was per-
formed according to a standard protocol with apparatus Volna - 2, 10 consecutive procedures, once daily.
Evaluation of UPDRS total and part III was performed on baseline, on days 11, 31 and 61. On day 11 all pa-
tients showed decrease in their both UPDRS total and part III. We lowered the levodopa doses of 6 patients in
Hoehn- Yahr stage III with greatest decrease of UPDRS. On days 31 and 61 UPDRS total and part III were
still lower. Our results demonstrate substantial effect of DWT on motor symptoms in late PD patients. All pa-
tients showed improvement, assessed by UPDRS, as the effect still lasted for 2 months after the physical ther-
apy, even slightly diminished on day 61, compared to day 11. According to our results and patients subjective
satisfaction reported, we could propose DWT become a part of the treatment strategy in late PD patients.
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INTRODUCTION
Late stage Parkinson`s disease (PD) is characterized by
motor fluctuations, dyskinesias and nonmotor off phenom-
ena. Levodopa, the "gold standard" drug therapy, dimin-
ishes its efficacy and starts displaying side effects.
Adjunctive therapy with dopamine agonists, COMT and
MAO B inhibitors, and amantadine is needed in order to in-
fluence motor symptoms and delay the increase of
levodopa doses.
Physical therapy is another option to achieve such goals.
Spectrum of methods is applied in the treatment of
neurodegenerative diseases. Decimeter waves therapy
(DWT) is one of possibilities as supplementary therapy in
late stage PD (1,4).
AIM
Assessment of the efficacy of DWT in late PD.
SUBJECTS AND METHOD
Twelve patients were included in the study (7 males), aged
65,83± 4,02 years, with 6,42± 1,51 years disease duration.
Seven were at Hoehn- Yahr stage III and remaining 5 at
stage IV (3,42± 0,52). Mean UPDRS total score sum was
39,25± 1,91, and mean UPDRS part III sum was 24,67±
2,1. Patients were on stable doses of levodopa (1150±
192,77 mg) and dopamine agonist pramipexole (3 mg).
All patients signed informed consent.
DWT was performed according to a standard protocol with
apparatus Volna - 2. Ten consecutive procedures were ap-
plied, once daily, from 6 to 8 minutes duration with gradu-
ated augmentation, olygothermic doses were used 20- 40
W. The emitter was placed horizontally on 5 cm over the
skin in the occipital region.
Evaluation of UPDRS total and part III was performed on
baseline, on days 11, 31 and 61.
RESULTS
All 12 patients completed the study. Procedures were well
tolerated, no side effects occurred.
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On day 11 all patients showed decrease in their both
UPDRS total and part III points (table 1). We lowered the
levodopa doses with 112,5± 20,92 mg of 6 patients in
Hoehn- Yahr stage III with greatest decrease of UPDRS.
On day 31 and 61 UPDRS total and part III were still lower
than on baseline (table 1).
On day 61 the point reduction of UPDRS total score
(UPDRS t 61) was 7,54%± 2,11% and of UPDRS motor
score (UPDRS m 61) was 16,77% ± 5,83% (Fig. 1 and 2).
DISCUSSION
Our results demonstrate substantial effect of DWT on mo-
tor symptoms in late PD patients. All patients showed im-
provement, assessed by UPDRS, as the effect still lasted for
2 months after the physical therapy, even slightly dimin-
ished on day 61, compared to day 11.
Enormous progress has been made in the treatment of Par-
kinson's disease, but many challenges still remain. Al-
though levodopa is the most effective symptomatic ther-
apy, a majority of patients start to experience side effects.
After the initial "honeymoon" period, which lasts usually
3-5 years and during which PD symptoms are generally
well controlled, most patients eventually develop
levodopa-related complications, particularly motor fluctua-
tions and dyskinesias (2).
All this imposes the search of new therapeutic strategies.
To the extent that neuroprotection slows or halts the pro-
gression of the disease, it must be implemented early. Al-
though a true neuroprotective drug is not yet available,
there are several guidelines that can be recommended for
the initial phases of PD therapy designed to minimize the
risks of complications from chronic levodopa therapy. An-
tioxidants, antiexcitatory drugs, and dopamine agonists,
have been postulated to exert a neuroprotective effect,
largely based on current hypotheses about the mechanisms
of cell death and neurodegeneration (2,5).
The role of physical therapy and rehabilitation is well
known in PD, but the spectrum of techniques may be suc-
cessfully enlarged with the introduction of DWT as routine
therapeutic option in late PD (3,5,6,7).
CONCLUSION
According to our results and patients subjective satisfaction
reported, we could propose DWT as a part of the treatment
strategy in late PD patients.
DWT is a non-invasive, well tolerated technique of brain
stimulation based on electromagnetic induction, which
have been used in PD patients and have been suggested as
possible therapeutic tool. In patients with late PD when
drug treatment tends to become limited over the years, and
the neurosurgical procedures are still costly and invasive,
non pharmacological approaches could gain their place as
supplementary treatment options.
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UPDRS
values
Baseline Day 11 Day 31 Day 61
UPDRS
total
39,25 ± 1,91 31,92 ± 2,58 33,3 ± 3,11 35,17 ± 2,95
UPDRS
part III
24,67 ± 2,1 17,58 ± 2,39 19,67 ± 2,64 20,58 ± 2,78
Table 1. UPDRS total and part III comparative values
for baseline and days 11, 31 and 61
Fig. 1. UPDRS total score values on baseline and on
days 11, 31 and 61
Fig. 2. UPDRS motor score values on baseline and on
days 11, 31 and 61
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